Clinical Trial

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Name: Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis — clinical trial record (NCT07146529)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRINAVIH

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The primary objective of the study is to determine the frequency of transmission of viruses carrying at least one antiretroviral resistance mutation in all participants newly diagnosed with HIV-1

Trial Details

NCT Number	NCT07146529
Lead Sponsor	ANRS, Emerging Infectious Diseases Collaborators: INSERM UMR S 1136, iPLesp
Conditions	HIV Seropositivity, HIV Drug Resistance, HIV Infections
Enrollment	30,060 participants
Start Date	2025-09
Primary Completion	2036-09 (estimated)
Study Completion	2036-09 (estimated)
Updated on ClinicalTrials.gov	2025-08-28